Price
344.95
+2.26%52W Range
Market Cap
₹1,835.35 Cr
Traded: ₹5.55 Cr (0.30%) 0.0x
Free Float: ₹890.15 Cr (0.62% of FF traded)
Volume · 60D trend
1.63 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | +13.0% | -- | -- | +8.0% | Decelerating |
| Profit | -- | -26.0% | -- | -- | -49.0% | Decelerating |
| Return | -- | -- | -26.0% | -42.0% | -- | Decelerating |
| ROE | -- | -- | +5.0% | -- | -- | -- |
Quarterly Results
Sep 2021
Jun 2021
Mar 2021
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Mar 2022PDF ↗ | Dec 2021PDF ↗ | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 110 | 121 | 108 | 102 | 91 | 113 | 96 | 99 | 85 | 106 | 62 | 85 | 71 | 76 | 69 | 68 |
| Expenses | 84 | 87 | 76 | 75 | 67 | 76 | 66 | 74 | 66 | 75 | 39 | 41 | 38 | 38 | 32 | 33 |
| Operating Profit | 26 | 34 | 32 | 27 | 25 | 37 | 30 | 25 | 19 | 30 | 23 | 44 | 33 | 38 | 37 | 35 |
| OPM % | 23.6% | 28.3% | 29.2% | 26.8% | 27.0% | 32.9% | 31.0% | 25.5% | 22.1% | 28.6% | 37.0% | 52.2% | 46.9% | 50.6% | 53.2% | 51.6% |
| Other Income | 6 | 7 | 7 | 6 | 3 | 4 | 1 | 8 | 3 | 3 | 3 | 3 | 2 | 1 | 2 | 1 |
| Interest | 6 | 6 | 6 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 3 | 0 | 1 | 2 | 1 | 1 |
| Depreciation | 27 | 29 | 25 | 22 | 20 | 20 | 17 | 14 | 11 | 12 | 10 | 7 | 5 | 5 | 5 | 3 |
| Profit Before Tax | -1 | 6 | 8 | 6 | 3 | 16 | 8 | 15 | 6 | 17 | 14 | 39 | 29 | 34 | 33 | 32 |
| Tax % | 9.1% | 27.6% | 32.9% | 40.6% | 41.3% | 34.5% | 34.7% | 30.8% | 36.4% | 39.5% | 26.7% | 24.9% | 25.7% | 25.8% | 25.5% | 25.4% |
| Net Profit | -1 | 4 | 5 | 3 | 2 | 10 | 5 | 10 | 4 | 10 | 10 | 29 | 21 | 25 | 25 | 24 |
| Exceptional Items | -- | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -- |
| EPS (Rs) | -0.3 | 0.8 | 0.9 | 0.6 | 0.3 | 1.9 | 1.0 | 1.9 | 0.8 | 1.9 | 1.9 | 5.5 | 4.0 | 4.9 | 4.9 | 1225.8 |
| Sales Growth (YoY) | -- | 7.3% | 12.8% | 3.1% | 7.7% | 6.6% | 54.9% | -- | -- | -- | -- | 25.7% | 17.3% | -- | -- | -- |
| Sales Growth (QoQ) | -- | 12.1% | 5.4% | 12.0% | -18.9% | 17.8% | -3.6% | 17.0% | -19.8% | 71.1% | -27.3% | 20.2% | -7.1% | 10.0% | 2.4% | -- |
| OP Growth (YoY) | 5.2% | -7.4% | 6.3% | 8.5% | 31.7% | 22.4% | 29.5% | -- | -- | -- | -- | 27.2% | -- | -- | -- | -- |
| OP Growth (QoQ) | -24.2% | 8.7% | 14.8% | 11.1% | -33.3% | 24.9% | 17.1% | 34.9% | -38.0% | 32.2% | -- | 33.8% | -13.9% | 4.7% | 5.5% | -- |
| Profit Growth (YoY) | -- | -61.0% | 13.0% | -68.0% | -56.0% | -1.0% | -47.0% | -- | -- | -- | -- | 25.0% | 2.0% | -- | -- | -- |
| EPS Growth (YoY) | -- | -58.9% | -4.0% | -67.9% | -56.6% | -1.0% | -47.1% | -- | -- | -- | -- | -99.5% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | -16.8% | 53.2% | 87.9% | -82.8% | 93.9% | -48.7% | 153.9% | -60.8% | 3.7% | -66.3% | 37.1% | -17.4% | 0.2% | -99.6% | -- |
| OP Margin | -- | 28.3% | 29.2% | 26.8% | 27.0% | 32.9% | 31.0% | 25.5% | 22.1% | 28.6% | 37.0% | 52.2% | 46.9% | 50.6% | 53.2% | 51.6% |
| Net Margin | -- | 3.5% | 4.7% | 3.2% | 1.9% | 9.1% | 5.5% | 10.4% | 4.7% | 9.8% | 16.1% | 34.7% | 30.4% | 32.7% | 35.9% | 34.9% |
| Material Cost % | -- | 34.1% | 32.6% | 32.5% | 32.1% | 33.6% | 32.6% | 32.9% | 32.6% | 31.4% | 26.9% | 22.4% | 22.1% | 20.9% | 18.0% | 23.5% |
| Employee Cost % | -- | 16.8% | 18.1% | 17.4% | 19.6% | 14.9% | 17.1% | 16.2% | 19.0% | 14.8% | 15.8% | 10.1% | 10.7% | 10.1% | 11.0% | 9.4% |
| P/S | 4.16 | 3.95 | 2.71 | 2.52 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 165.05 | 116.54 | 55.24 | 49.43 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 2.89 | 2.63 | 1.79 | 1.62 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Transcript of Earnings Conference Call for the quarter ended June 30, 2026
Intimation of Audio Recording of Conference Call
Newspaper Publication of Financial Results for the quarter ended June 30, 2026
Investor Presentation for the quarter ended June 30, 2026.
Update regarding the Finalization of the date of 43rd Annual General Meeting of the Company.
Board Meeting held on Monday, August 10, 2026 to approve the Unaudited Standalone & Consolidated Financial Results of the Company for the Quarter ended June 30, 2026.
Outcome of the Board meeting held on Monday, August 10, 2026 to approve the Unaudited Standalone & Consolidated Financial Results of the Company for the quarter ended June 30, 2026
Intimation of Schedule of Analyst/Institutional Investor Meeting(s) to be held on August 13, 2026.
Tarsons Products Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve the Unaudited Standalone and ....
Certificate under Regulation 74 (5) of the SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2026.
Closure of Trading Window for the quarter ended June 30, 2026
Reply on Clarification sought on significant movement in price of Tarsons Products Limited.
The Exchange has sought clarification from Tarsons Products Ltd on June 18, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Reply on Clarification sought for spurt on volume of Tarsons Products Limited.
The Exchange has sought clarification from Tarsons Products Ltd on June 17, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited.
Intimation of resignation of Senior Management Personnel of the Company - Mr. Subhra Shankar Bose, Human Resource Head.
Intimation of Schedule of Analyst/Institutional Investor Meeting(s)
Intimation of Schedule of Analyst/Institutional Investor Meeting(s)
Transcript of Earning Call for the quarter and financial year ended March 31, 2026
Intimation of Audio Recording of Conference Call to discuss the financial performance/audited Financial Results (Consolidated & Standalone) of the Company for the quarter and financial ....
Investor Presentation for the Quarter and Financial Year ended March 31, 2026
Newspaper Publication of Financial Results for the Quarter and Financial Year ended March 31, 2026
Re-appointment of Internal Auditor of the Company for the Financial Year 2026-27.
Approved Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026.
Outcome of the Board meeting held on Friday, May 22, 2026 for the quarter and financial year ended March 31, 2026
Annual Secretarial Compliance Report for the financial year ended March 31, 2026
Intimation of Schedule of Investor/Analyst Conference Call to discuss the financial and operational performance for the quarter and financial year ended March 31, 2026
Tarsons Products Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 ,inter alia, to consider and approve the Audited Standalone and ....
Update on Senior Management Personnel (SMP)
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Appointment of Mr. Vinesh Mohan Kriplani (DIN: 08212644) as Non-Executive Independent Director of the Company.
Outcome of Postal Ballot
Scrutinizer Report
Intimation of Credit Rating
Closure of trading window for the quarter ended March 31, 2026
Intimation of Newspaper Advertisement for the dispatch of Postal Ballot Notice.
Intimation of dispatch of Postal Ballot Notice
Intimation of Transcript of Earnings Conference Call for the quarter and nine months ended December 31, 2025
Intimation of Schedule of Analyst/Institutional Investor Meeting(s) pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Newspaper Publication of Financial Results for quarter and nine months ended December 31, 2025.
Intimation of Audio Recording of Conference Call for the quarter and nine months ended December 31, 2025
Announcement of Equity infusion in our wholly owned subsidiary, Singapore
Intimation of Investor Presentation for the Quarter and Nine months ended December 31, 2025
Intimation of Resignation of Mr. Girish Paman Vanvari (DIN: 07376482)
Intimation of Appointment of Mr. Vinesh Mohan Kriplani (DIN: 08212644) and Resignation of Mr. Girish Paman Vanvari (DIN: 07376482)
Intimation of Appointment of Mr. Vinesh Mohan Kriplani (DIN: 08212644) and Resignation of Mr. Girish Paman Vanvari (DIN: 07376482)
Results for the quarter and nine months ended December 31, 2025.
Outcome of the Board Meeting held on Friday, February 06, 2026, to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and ....
Intimation of Schedule of Investor/Analyst Conference Call to discuss the financial and operational performance for the quarter and nine months ended December 31, 2025.
Credit Ratings
6Concalls
20Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025Jun 2025
30 Jun 2025Feb 2025
28 Feb 2025Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024Aug 2024
31 Aug 2024Jun 2024
30 Jun 2024Feb 2024
29 Feb 2024Feb 2024
29 Feb 2024Dec 2023
31 Dec 2023Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023Jun 2023
30 Jun 2023Feb 2023
28 Feb 2023Nov 2022
30 Nov 2022Aug 2022
31 Aug 2022Jun 2022
30 Jun 2022Feb 2022
28 Feb 2022Held by ETFs
1 ETFs hold TARSONS · sorted by weight
Held by Mutual Funds
1 schemes hold TARSONS · sorted by weight